4//SEC Filing
TULLMAN GLEN 4
Accession 0001179110-21-001277
CIK 0001477449other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:03 PM ET
Size
8.6 KB
Accession
0001179110-21-001277
Insider Transaction Report
Form 4
TULLMAN GLEN
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-01$5.26/sh+164,931$867,537→ 440,724 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-01−164,931→ 494,794 totalExercise: $5.26Exp: 2021-04-30→ Common Stock (164,931 underlying) - Sale
Common Stock
2021-02-01$262.61/sh−164,931$43,312,530→ 275,793 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
- [F2]Represents the weighted average price of transactions ranging from $257.01 to $266.64. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The option vested in full on October 30, 2020.
Documents
Issuer
Teladoc Health, Inc.
CIK 0001477449
Entity typeother
Related Parties
1- filerCIK 0001213349
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:03 PM ET
- Size
- 8.6 KB